source
- Cambrian’s experimental longevity drug shown to mimic exercise effectsCambrian Therapeutics reported early data on a new compound aimed at extending healthy lifespan by reproducing some benefits of physical activity. The preclinical studies described in the newslett…
- Prepping for peptidesIt wasn’t too many years ago when we were busy theorizing about the market opportunity for GLP-1 weight loss drugs. Now, the big question is the moneymaking potential for other peptides that might…Endpoints · 2mo ago↗ source
- Pfizer CFO to step down; Denali sells a regulatory fast-passA search is underway for a successor to Dave Denton, who took a job outside the pharmaceutical industry. Elsewhere, a new kind of Duchenne gene therapy got venture backing and a GSK deal paid divid…